Pediatr. praxi. 2013;14(2):114-117

Resistance of pediatric bacterial pathogens and options of antibiotic therapy

prof.MUDr.Milan Kolář, Ph.D.1, MUDr.Miroslava Htoutou Sedláková1, Mgr.Luboslava Čekanová, Ph.D.2
1 Ústav mikrobiologie FNOL a LF UP v Olomouci
2 Laboratoře Mikrochem, a. s., Olomouc

The present article defines resistance of the most frequent bacterial pathogens to antimicrobial agents in pediatric age in communityacquired

as well as nosocomial infections. Based on these data, the options of antibiotic therapy are formulated.

Keywords: bacterial infection, pediatric age, antibiotic therapy

Published: May 1, 2013  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kolář M, Htoutou Sedláková M, Čekanová L. Resistance of pediatric bacterial pathogens and options of antibiotic therapy. Pediatr. praxi. 2013;14(2):114-117.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Neu HC. The crisis in antibiotic resistance. Science 1992; 257: 1064-1073. Go to original source... Go to PubMed...
    2. Hanulík V, Uvízl R, Husičková V, et al. Bakteriální původci pneumonií u pacientů v intenzivní péči. Klin Mikrobiol Inf Lék 2011; 17: 134-139.
    3. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676-685. Go to original source... Go to PubMed...
    4. Rello J, Torres A, Ricart M, et al. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillinresistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994; 150: 1545-1549. Go to original source... Go to PubMed...
    5. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Available from: http://www.eucast.org/clinical_breakpoints.
    6. CLSI. Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. M100-S19. 2009.
    7. Čekanová L, Kolář M. Vývoj rezistence komunitních respiračních patogenů k antimikrobním přípravkům v olomouckém regionu. Interní Med. 2007; 9: 405-407.
    8. Kolář M. Antimikrobní léčba komunitních bakteriálních infekcí - je nutná změna? Pediatr Praxi 2009 (Příloha, ,Zimní období v ordinaci a lékárně): 57-62.

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.